It has shown statistically significant but minor progress, with studies suggesting a decrease in cognitive decline in Alzheimer's participants compared with a control group given a placebo instead. References Further reading External links Alzheimer's disease Breakthrough therapy Monoclonal antibodies Orphan drugs Treatment of Alzheimer's disease